Skip to main content
. 2004 Aug;48(8):3154–3158. doi: 10.1128/AAC.48.8.3154-3158.2004

TABLE 1.

Mean percentage and range of survival of mice 10 days after infection with Aspergillus and combination therapy with G-CSF and POS or POS monotherapy

Treatmenta Mean % of mice surviving infection withb
A. fumigatus ND158c A. fumigatus ND208c A. flavus ND83d,f A. fumigatus ND208 INe
G-CSF
    0 0 (0) 0 (0) 0 0
    125 0 (0) 0 (0) 0 0
    600 0 (0) 0 (0) 0 0
POS
    0 0 (0) 0 (0) 0 0
    5 0 (0) 5.6 (0-16.7) 33.3 0
    25 8.3 (0-16.7) 27.8 (8.3-41.7) 75.0 20.0
    100 27.8 (16.7-41.7) 41.7 (16.7-66.7) 83.3 30.0
G-CSF/POS
    125/0 0 (0) 0 (0) 0 0
    125/5 5.6 (0-16.7) 8.3 (0-25.0) 8.3 0
    125/25 5.6 (0-16.7) 11.1 (0-33.3) 58.3 10.0
    125/100 19.4 (0-33.3) 22.2 (0-66.7) 66.7 0
    600/0 0 (0) 0 (0) 0 0
    600/5 2.8 (0-8.3) 8.3 (0-25.0) 33.3 0
    600/25 5.6 (0-16.7) 19.5 (0-41.7) 66.7 10.0
    600/100 19.4 (16.7-25.0) 38.9 (25.0-66.7) 66.7 30.0
a

Treatment doses are given in micrograms per kilogram per day for G-CSF and milligrams per kilogram per day for POS.

b

Values in parentheses are ranges of percent survival among experiments.

c

Data represent means of the results of three independent experiments with 36 mice.

d

Data represent the results of a single experiment with 12 mice.

e

Data represent the results of a single experiment with 10 mice. IN, intranasal infection.

f

POS was given at 0.2, 1, or 10 mg/kg/day. No significant difference was observed between the survival of mice in combination therapy and the survival of those in monotherapy groups (P value of >0.05 by Wilcoxon and log rank analyses).